Search

The Sudan Journal of Medical Sciences is a leading scholarly medical journal in Sudan that publishes high-quality research addressing health challenges faced by the Sudanese health community. Despite the challenges caused by the ongoing conflict in Sudan, the journal has continued to collect and publish scholarly output, with a significant increase in readership and article views in 2023. The journal has a diverse readership from 203 countries, with the largest number of readers based in the United States. The journal has faced internet connectivity issues and financial obligations, but has received support from donors and organizations to maintain its operations. The journal aims to represent the wide spectrum of the medical academic community in Sudan and has an ongoing call for support. [Extracted from the article]

Context: The COVID-19 pandemic has impacted healthcare environment.Objective: To determine the impact of the pandemic on self-reported outcomes in patients with adrenal insufficiency (AI).Design and Setting: Prospective longitudinal survey study at 2 tertiary centers.Participants: Patients with AI.Intervention: Patient-centered questionnaire.Main Outcome Measures: Depression Anxiety Stress Scales-21, Short Form-36, and AI self-management.Results: Of 342 patients, 157 (46%) had primary AI, 109 (32%) had secondary AI, and 76 (22%) had glucocorticoid-induced AI. When compared to prepandemic, daily glucocorticoid dose and number of adrenal crises did not change. However, patients reported a higher financial impact from AI (34% vs 23%, P = 0.006) and difficulty accessing medical care (31% vs 7%, P < 0.0001) during the pandemic. A third of patients reported difficulty managing AI during the pandemic. After adjusting for duration and subtypes of AI, younger patients [odds ratio (OR) 2.3, CI 95% 1.3-4.1], women (OR 3.7, CI 95% 1.9-7.1), poor healthcare access(OR 4.2, CI 95% 2.3-7.7), lack of good insurance support (OR 2.8, CI 95% 1.3-5.9), and those with a higher financial impact (OR 2.3, CI 95% 1.3-4.3) reported greater difficulties managing AI. Patients were more likely to report a higher anxiety score (≥8) if they found managing AI challenging during the pandemic (OR 3.0, CI 95% 1.3-6.9), and had lower Physical Component Summary (OR 4.9, CI 95% 2.2-11.0) and Mental Component Summary (OR 4.1, CI 95% 1.8-9.5) scores prior to the pandemic.Conclusions: A third of patients with AI reported difficulties with management of AI during the pandemic, particularly in younger patients, women, and those with poor healthcare access. [ABSTRACT FROM AUTHOR]